Latest Earnings Results: Q3 '26
Estimated EPS
$0.02
Reported EPS
-$0.79
Surprise
-4050%
Estimated Rev
$37.28M
Reported Rev
$35.9M
Surprise
-3.7%
Omeros expects to fund more than 12 months of operations using current cash, cash equivalents, short-term investments and YARTEMLEA sales; Q4 2026 R&D and SG&A expenses are expected to be higher and slightly higher, respectively.
Generated by Stocktwits using AI and company-reported earnings data for Q3 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.
Historical Earnings
Quarterly
Annual
EPS
Revenue
| Fiscal Period | Estimated | Reported | Surprise | Result |
|---|---|---|---|---|
Q4 '26 | $0.16 | -- | -- | N/A |
Q3 '26 | $0.02 | -$0.79 | -4050.00% | MISSED |
Q2 '26 | -$0.27 | $0.15 | 155.91% | BEAT |
Q1 '26 | -$0.39 | $0.62 | 260.77% | BEAT |
Q4 '25 | -$0.57 | $0.98 | 271.93% | BEAT |